Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VUG vs GSK✓SelectedUSD · GSKVUG vs GSK performance historyLatest closeAs of+0.38%11/18
Stock and ETF performance explorer

VUG vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+380.6%
GSK return
+101.2%
Excess return
+279.4%
Maximum drawdown
-35.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.4%-1.3%+1.7%+0.8%
7D-4.1%-3.1%-0.9%-3.2%
30D-8.0%-0.9%-7.1%-7.8%
3M-6.9%-4.2%-2.7%-6.0%
6M-5.9%-1.6%-4.3%-6.2%
YTD+0.9%+2.6%-1.7%-1.4%
1Y+4.1%+6.2%-2.1%+0.6%
3Y+68.7%+55.0%+13.7%+37.8%
5Y+55.3%+42.8%+12.5%+28.8%
10Y+380.6%+102.1%+278.5%+241.3%
All+380.6%+101.2%+279.4%+241.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling